Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Isa Mambetsariev's publication output changed over time?
ScholarIQpublication output · 2018–2025
Output grew0% over the shown period — from 1 works in 2018 to 1 in 2025.
1
1
3
3
2
1
201820192020202120232025
What are the most-cited papers on Isa Mambetsariev?
ScholarIQmost cited works
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Katherine G. Roth, Isa Mambetsariev, Prakash Kulkarni, Ravi Salgia
S64855341. 2019230 CitationsOPEN ACCESS
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, Arin Nam, Martin Sattler
Cell Reports Medicine. 2021161 CitationsOPEN ACCESS
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
Jacqueline V. Aredo, Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda, Caroline E. McCoach, Jonathan W. Riess, Elwyn C. Cabebe, Jarushka Naidoo, Tariq Abuali, Ravi Salgia, Billy W. Loo, Maximilian Diehn, Summer S. Han, Heather A. Wakelee
Journal of Thoracic Oncology. 2021130 CitationsOPEN ACCESS
Integration of artificial intelligence in lung cancer: Rise of the machine
Colton Ladbury, Arya Amini, Ameish Govindarajan, Isa Mambetsariev, Dan J. Raz, Erminia Massarelli, Terence M. Williams, Andréi S. Rodin, Ravi Salgia
Cell Reports Medicine. 202372 CitationsOPEN ACCESS
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Atish Mohanty, Arin Nam, Saumya Srivastava, Jeff Jones, Brett Lomenick, Sharad S. Singhal, Linlin Guo, Hyejin Cho, Aimin Li, Amita Behal, Tamara Mirzapoiazova, Erminia Massarelli, Marianna Koczywas, Leonidas Arvanitis, Tonya C. Walser, Victoria Villaflor, Stanley R. Hamilton, Isa Mambetsariev, Martin Sattler, Mohd W. Nasser, Maneesh Jain, Surinder K. Batra, Raffaella Soldi, Sunil Sharma, Marwan Fakih, Saswat K. Mohanty, Avijit Mainan, Xiwei Wu, Yihong Chen, Yanan He, Tsui‐Fen Chou, Susmita Roy, John Orban, Prakash Kulkarni, Ravi Salgia
S2737427234. 202372 CitationsOPEN ACCESS
Related on ScholarIQ
City Of Hope National Medical Center
Institution
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Paper
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
Paper
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
Paper
Integration of artificial intelligence in lung cancer: Rise of the machine
Paper
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Paper